PMID: 2497858Apr 8, 1989Paper

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey

BMJ : British Medical Journal
C G IslesA F Lever

Abstract

The relation between plasma cholesterol concentration and mortality from coronary heart disease, incidence of and mortality from cancer, and all cause mortality was studied in a general population aged 45-64 living in the west of Scotland. Seven thousand men (yielding 653 deaths from coronary heart disease, 630 new cases of cancer, and 463 deaths from cancer) and 8262 women (322 deaths from coronary heart disease, 554 new cases of cancer, and 395 deaths from cancer) were examined initially in 1972-6 and followed up for an average of 12 years. All cause mortality was not related to plasma cholesterol concentration. This was largely a consequence of a positive relation between cholesterol values and mortality from coronary heart disease being balanced by inverse relations between cholesterol and cancer and between cholesterol and other causes of death. These changes were highly significant for coronary heart disease and cancer in men and significant for coronary heart disease and other causes of death in women. The inverse association between cholesterol concentration and cancer in men was strongest for lung cancer, was not merely a function of the age at which a subject died, was present for the incidence of cancer as well as mo...Continue Reading

References

Jun 1, 1979·International Journal of Epidemiology·O TurpeinenE Paavilainen
Jun 19, 1987·JAMA : the Journal of the American Medical Association·D H BlankenhornL Cashin-Hemphill
Sep 1, 1988·Journal of the American College of Cardiology·M F Oliver
Apr 1, 1986·Journal of Hypertension·C G IslesJ W Robertson
Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Dec 25, 1986·The New England Journal of Medicine·S A TörnbergG A Eklund
Jan 1, 1986·Journal of Chronic Diseases·R A Hiatt, B H Fireman
Apr 12, 1985·JAMA : the Journal of the American Medical Association
Sep 7, 1974·British Medical Journal·V M HawthorneD G Beevers
Nov 1, 1970·Circulation·P Leren
Mar 8, 1980·Lancet·G Rose, M J Shipley
Jan 1, 1984·Epidemiologic Reviews·A J McMichaelD G Zaridze
Aug 13, 1983·British Medical Journal·M R AldersonA G Whitfield
Aug 15, 1983·Klinische Wochenschrift·B Peterson, E Trell
Jan 16, 1982·British Medical Journal·J D KarkC G Hames
Mar 27, 1982·British Medical Journal·P DucimetiereJ Richard
Jul 1, 1981·American Journal of Epidemiology·A KaganA Nomura
Jul 1, 1981·American Journal of Epidemiology·D KozarevicT Dawber
Feb 2, 1980·British Medical Journal·R BeagleholeE F Eyles
Sep 1, 1980·American Journal of Epidemiology·F CambienJ Richard
Jan 16, 1981·JAMA : the Journal of the American Medical Association·R R WilliamsT R Dawber
Feb 8, 1964·Lancet·G A ROSEE A CROWLEY

❮ Previous
Next ❯

Citations

Apr 1, 1992·Cardiovascular Drugs and Therapy·M F Oliver
Jan 1, 1995·Molecular Aspects of Medicine·M J Halpern
Jan 1, 1992·Progress in Lipid Research·M I Gurr
Aug 1, 1994·Social Science & Medicine·D M Atrens
Jan 11, 2003·The American Journal of Cardiology·Rachel DanknerHenrietta Reicher-Reiss
Feb 8, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·J R PetersenM G Bissell
Mar 21, 1998·Cardiology Clinics·S J Lewis
Jan 3, 1991·The New England Journal of Medicine·R Mornex, B Hugues
Feb 23, 1995·The New England Journal of Medicine·G N LevineJ A Vita
Jun 29, 1995·The New England Journal of Medicine·J W Rich-EdwardsJ E Buring
Jan 1, 1991·Nutrition and Cancer·P KnektL Teppo
Jan 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M StrasakUNKNOWN VHM&PP Study Group
Dec 14, 2011·QJM : Monthly Journal of the Association of Physicians·U RavnskovP J Rosch
Feb 1, 1994·Australian and New Zealand Journal of Medicine·R J Simes
May 6, 1989·BMJ : British Medical Journal·R PetoT Brun
Jul 1, 1989·BMJ : British Medical Journal·A R Walker, B F Walker
Aug 11, 1990·BMJ : British Medical Journal·M F MuldoonK A Matthews
Oct 19, 1991·BMJ : British Medical Journal·L E RamsayP R Jackson
Aug 12, 1995·BMJ : British Medical Journal·G WannametheeM Walker
Sep 23, 1995·BMJ : British Medical Journal·W M Monique Verschuren, D Kromhout
Dec 3, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Linsay GrayG David Batty
Jul 1, 1991·Cancer Causes & Control : CCC·M R Law, S G Thompson
Jan 1, 1996·Cancer Causes & Control : CCC·R G ZieglerC A Swanson
Apr 29, 1989·BMJ : British Medical Journal
May 20, 1989·BMJ : British Medical Journal
Jun 7, 2005·Expert Opinion on Drug Safety·Beatrice Alexandra Golomb
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·N M Kaplan
Apr 1, 1991·Annals of Medicine·S A Törnberg
Oct 1, 1994·The American Journal of the Medical Sciences·C J GlueckJ Speirs
Jul 30, 2011·The Urologic Clinics of North America·Keith R Solomon, Michael R Freeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.